Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

SVB Leerink Downgrades Decibel Therapeutics to Market Perform, Lowers Price Target to $2

SVB Leerink analyst Mani Foroohar downgrades Decibel Therapeutics (NASDAQ:DBTX) from Outperform to Market Perform and lowers the price target from $7 to $2.

byBenzinga Newsdesk

March 15, 2023

1 minute read

SVB Leerink analyst Mani Foroohar downgrades Decibel Therapeutics (NASDAQ:DBTX) from Outperform to Market Perform and lowers the price target from $7 to $2.

Morgan Stanley Maintains Equal-Weight on Core Laboratories, Lowers Price Target to $20

By Benzinga Newsdesk

Today, 4:49 PM

Morgan Stanley analyst Connor Lynagh maintains Core Laboratories (NYSE:CLB) with a Equal-Weight and lowers the price target from $22 to $20.

CLB

BMO Capital Maintains Outperform on Salesforce.com, Raises Price Target to $310

By Benzinga Newsdesk

Today, 4:49 PM

BMO Capital analyst Keith Bachman maintains Salesforce.com (NYSE:CRM) with a Outperform and raises the price target from $280 to $310.

CRM

General Dynamics’ IT Unit Wins $162M Defense Info Systems Agency Contract For Mgmt. Of Phase 3 Production Of Other Transaction Authority Deal

By Benzinga Newsdesk

Today, 4:49 PM

General Dynamics Information Technology (GDIT), a business unit of General Dynamics (NYSE:GD), announced today that it has been awarded the Identity, Credential and Access Management (ICAM) Other Transaction Authority